Correlation Between Cantargia and XSpray Pharma
Can any of the company-specific risk be diversified away by investing in both Cantargia and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cantargia and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cantargia AB and XSpray Pharma AB, you can compare the effects of market volatilities on Cantargia and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cantargia with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cantargia and XSpray Pharma.
Diversification Opportunities for Cantargia and XSpray Pharma
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cantargia and XSpray is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cantargia AB and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Cantargia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cantargia AB are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Cantargia i.e., Cantargia and XSpray Pharma go up and down completely randomly.
Pair Corralation between Cantargia and XSpray Pharma
Assuming the 90 days trading horizon Cantargia AB is expected to under-perform the XSpray Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Cantargia AB is 1.02 times less risky than XSpray Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The XSpray Pharma AB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 3,260 in XSpray Pharma AB on August 29, 2024 and sell it today you would earn a total of 935.00 from holding XSpray Pharma AB or generate 28.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cantargia AB vs. XSpray Pharma AB
Performance |
| Timeline |
| Cantargia AB |
| XSpray Pharma AB |
Cantargia and XSpray Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cantargia and XSpray Pharma
The main advantage of trading using opposite Cantargia and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cantargia position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.The idea behind Cantargia AB and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| XSpray Pharma vs. Xbrane Biopharma AB | XSpray Pharma vs. Hansa Biopharma AB | XSpray Pharma vs. Cantargia AB | XSpray Pharma vs. Vicore Pharma Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |